SA saves R2.2bn in HIV drug tender

29th November 2012, Comments 0 comments

South Africa achieved a massive R2.2-billion cost reduction in the R5.9-billion tender awarded to three pharmaceutical companies on Thursday for single-dose antiretroviral ARV drugs for the government's HIV treatment campaign.

0 Comments To This Article